ORTHOPEDIATRICS CORP 8-K

What Happened

• OrthoPediatrics Corp. (KIDS) filed a Form 8-K on April 30, 2026 under Item 7.01 (Regulation FD disclosure) to announce that its executive officers will make presentations to investors and analysts.
• The company attached an investor presentation dated April 2026 as Exhibit 99.1, which the officers intend to use, in whole or in part, during those presentations. The filing also includes the interactive cover page data (Exhibit 104). The report was signed by Daniel J. Gerritzen, General Counsel and Secretary.

Key Details

• Filing date: April 30, 2026 (Form 8-K).
• Item reported: 7.01 — Regulation FD Disclosure.
• Exhibit filed: 99.1 — Investor Presentation dated April 2026 (and 104 — interactive cover page file).
• The disclosure pertains to upcoming investor/analyst presentations; the 8-K does not report earnings, revenue, executive changes, mergers, or other financial results.

Why It Matters

• This filing provides the official presentation materials the company will use with investors and analysts, improving transparency about the information OrthoPediatrics plans to share.
• Retail investors should review Exhibit 99.1 for any operational or strategic updates; note the 8-K itself does not include quarterly results, earnings figures, or corporate transaction announcements.
• Because presentation slides can include forward‑looking statements or other material information, investors may want to read the slides and accompanying disclaimers before making decisions.